Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
Authors
Keywords
Intratumoral peptide injection, Antigen, Immunotherapy, Cytotoxic T lymphocyte
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 62, Issue 4, Pages 639-652
Publisher
Springer Nature
Online
2012-11-10
DOI
10.1007/s00262-012-1366-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer
- (2012) Sumiya Ishigami et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: Unusually high frequency of down-regulation in breast cancer tissues
- (2012) Toshihiko Torigoe et al. PATHOLOGY INTERNATIONAL
- Clinical implication of HLA class I expression in breast cancer
- (2011) Koichi Kaneko et al. BMC CANCER
- HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells
- (2011) Toshiaki Yoshikawa et al. CANCER SCIENCE
- CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection
- (2010) Noriyuki Yamada et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer
- (2010) E. M. de Kruijf et al. CLINICAL CANCER RESEARCH
- Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
- (2009) I. F. Robey et al. CANCER RESEARCH
- The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion
- (2009) A. S. Silva et al. CANCER RESEARCH
- Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
- (2009) Hirofumi Shirakawa et al. CANCER SCIENCE
- Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
- (2009) Mary L. Disis et al. JOURNAL OF CLINICAL ONCOLOGY
- Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
- (2008) Lotte Engell-Noerregaard et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic cell vaccination and immune monitoring
- (2008) E. H. J. G. Aarntzen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Improved Tumor Immunity Using Anti-Tyrosinase Related Protein-1 Monoclonal Antibody Combined with DNA Vaccines in Murine Melanoma
- (2008) Y. M. Saenger et al. CANCER RESEARCH
- Recent Advances in Cancer Vaccines: An Overview
- (2008) K. Itoh et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now